NeuroVive Pharmaceutical AB (NVP) is traded on Stockholm Stock Exchange in Sweden. It is located in Lund, and employs 15 people. The company currently falls under 'Small-Cap' category with current market capitalization of 202.26 M. NeuroVive Pharmaceutical AB operates under Healthcare
sector and is part of Pharmaceuticals And Biosciences
industry. This company has 50.57 M outstanding shares.
NEUROVIVE PHARMA has accumulated about 46.98 M in cash with (55.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check NeuroVive Pharmaceutical Probability Of Bankruptcy